Ancora Advisors’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Ancora Advisors’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,500	Closed	-$105	–	1966
2024 Q2	$105	Hold	1,500	–	–	﹤0.01%	1783
2024 Q1	$105	Hold	1,500	–	–	﹤0.01%	1769
2023 Q4	$105	Hold	1,500	–	–	﹤0.01%	1689
2023 Q3	$105	Hold	1,500	–	–	﹤0.01%	1731
2023 Q2	$105	Hold	1,500	–	–	﹤0.01%	1748
2023 Q1	$105	Hold	1,500	–	–	﹤0.01%	1891
2022 Q4	$0	Hold	1,500	–	–	﹤0.01%	2318
2022 Q3	$0	Hold	1,500	–	–	﹤0.01%	2423
2022 Q2	$0	Buy	+1,500	New	+$261	﹤0.01%	2595

Ancora Advisors's ZVSAW Position: Q3 2024 in Review

Ancora Advisors sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q3 2024, closing a stake of 1,500 shares — an estimated $105 sold.

Ancora Advisors first reported a position in ZVSAW in Q2 2022 and held it in 9 quarters. The position peaked at $105 in Q2 2024. 0 funds tracked by Wall St. Rank hold ZVSAW as of Q3 2024.

Ancora Advisors reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q3 2024 after selling out during the quarter.
Ancora Advisors sold 1,500 ZyVersa Therapeutics, Inc. Warrants shares in Q3 2024, an estimated $105.
Ancora Advisors first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q2 2022 and held it in 9 quarters.
Ancora Advisors's ZyVersa Therapeutics, Inc. Warrants position peaked at $105 in Q2 2024.
0 funds tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q3 2024.

Based on Ancora Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.